Beneficial effects of nandrolone decanoate in wasting associated with HIV

Journal of the Indian Medical Association

Volumn 107, Issue 5, 2009, Pages 295-299

  Saha, Bibhuti ^a   Rajadhyaksha, Girish C ^b   Ray, Subrat K ^c  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^b LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^c Organon (India) Limited   (India)

Author keywords

Antiretroviral therapy; HIV infection; Nandrolone decanoate; Wasting

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NANDROLONE DECANOATE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE; ANABOLIC AGENT; DRUG DERIVATIVE; NANDROLONE;

ABDOMINAL FULLNESS; ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; BACKACHE; BELCHING; BODY ACHE; BODY FAT; BODY MASS; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; COUGHING; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC PAIN; EYE REDNESS; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIAN; INJECTION SITE PAIN; LABORATORY TEST; LEG PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NOSE DISCHARGE; OPEN STUDY; OUTCOME ASSESSMENT; PENILE SWELLING; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCROTAL SWELLING; SYMPTOM; THORAX PAIN; TINGLING SENSATION; TREATMENT DURATION; TREATMENT OUTCOME; VERTIGO; WASTING SYNDROME; WEAKNESS; WEIGHT REDUCTION; ADOLESCENT; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; INDIA; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANABOLIC AGENTS; ANALYSIS OF VARIANCE; HIV WASTING SYNDROME; HUMANS; INDIA; MALE; MIDDLE AGED; NANDROLONE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 73349105626     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Polsky B, Kotler D, Steinhart C - Treatment of guidelines for HIV associated wasting. HIV Clin Trials 2004; 5: 50-61.
2. Wanke C, Kotler D and HIV wasting collaborative consensus committee - The Collaborative recommendation: the approach to diagnosis and treatment of HIV wasting. J Acquir Immune Defic Syndr Hum Retrovirol 2004; S37: S 284-8.
3. Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, et al - E-1696 Study Investigators : effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med 2006; 7: 146-55.
4. Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, et al - A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment. J Clin Endocrinol Metab 2005; 90: 4474-82.
5. Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, et al - AIDS Clinical Trials Group 329 Study Team; National Institute of Allergy and Infectious Diseases Adult AIDS Clinical Trials Group: nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss. Arch Intern Med 2005; 165: 578-85.
6. Cuerda C, Zugasti A, Breton I, Camblor M, Miralles P, Garcia P - Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men. Nutr Clin Pract 2005; 20: 93-7. (Pubitemid 40261944)
7. Hassager C, Podenphant J, Riis BJ, Johansen JS, Jensen J. Christiansen C - Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women. Metabolism 1989; 38: 238-42. (Pubitemid 19071718)
8. Phadtare JM, Ghorpade SV, Sovani VB, Gaikwad SN, Meshram P, Ray SK - Role of nandrolone decanoate in the management of pulmonary tuberculosis: an open - label randomized, comparative clinical study. Indian Practitioners 2006; 59: 1-10.
9. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, et al - Recombinant human growth hormone in patients with HIV-associated wasting: a randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 873-82.
10. Moyle GJ, Daar ES, Gertner JM, Gertner JM, Kotler KP, Melchior J, et al - Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol 2004; 35: 367-75. (Pubitemid 38332797)
11. Hsu Jean WC, Pencharz PB, Macallan D, Tomkins A - Macronutrients and HIV/AIDS : A Review of Current Evidence, Durban, South Africa 10-13 April 2005. Geneva : Department of Nutrition for Health and Development, World Health Organization, 2005.